Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Julphar
Colorcon
Chubb
AstraZeneca
Accenture
Moodys
Harvard Business School
UBS

Generated: December 10, 2018

DrugPatentWatch Database Preview

Drug Price Trends for HYDROXYUREA

« Back to Dashboard

Drug Price Trends for HYDROXYUREA

Average Pharmacy Cost for HYDROXYUREA

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
HYDROXYUREA 500 MG CAPSULE 68084-0284-11 0.29585 EA 2018-11-21
HYDROXYUREA 500 MG CAPSULE 00555-0882-02 0.29585 EA 2018-11-21
HYDROXYUREA 500 MG CAPSULE 68084-0284-01 0.29585 EA 2018-11-21
HYDROXYUREA 500 MG CAPSULE 49884-0724-01 0.29585 EA 2018-11-21
HYDROXYUREA 500 MG CAPSULE 68084-0284-11 0.28090 EA 2018-10-17
HYDROXYUREA 500 MG CAPSULE 00555-0882-02 0.28090 EA 2018-10-17
HYDROXYUREA 500 MG CAPSULE 68084-0284-01 0.28090 EA 2018-10-17
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for HYDROXYUREA

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Glossary
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
HYDREA CAP Bristol-Myers Squibb Company 00003-0830-50 100 102.18 1.02180 EA 2018-05-01 - 2023-04-30 Big4
HYDREA CAP Bristol-Myers Squibb Company 00003-0830-50 100 137.20 1.37200 EA 2018-05-01 - 2023-04-30 FSS
DROXIA 200MG CAPSULES Bristol-Myers Squibb Company 00003-6335-17 60 33.99 0.56650 EA 2018-05-01 - 2023-04-30 Big4
DROXIA 200MG CAPSULES Bristol-Myers Squibb Company 00003-6335-17 60 45.64 0.76067 EA 2018-05-01 - 2023-04-30 FSS
DROXIA 300MG CAPSULES Bristol-Myers Squibb Company 00003-6336-17 60 33.99 0.56650 EA 2018-05-01 - 2023-04-30 Big4
DROXIA 300MG CAPSULES Bristol-Myers Squibb Company 00003-6336-17 60 45.64 0.76067 EA 2018-05-01 - 2023-04-30 FSS
DROXIA 400MG CAPSULES Bristol-Myers Squibb Company 00003-6337-17 60 36.37 0.60617 EA 2018-05-01 - 2023-04-30 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
US Army
Moodys
Cipla
Daiichi Sankyo
Queensland Health
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: